Forecasting the amount and cost of medicine to treat type 2 diabetes mellitus in Nepal using knowledge on medicine usage from a developed country
ConclusionsWith the medicines for only T2DM projected to cost about 25% of the entire health budget, the planned health insurance seems unaffordable if patients are treated with the same medicines as those in one of the best healthcare systems in the world. The government needs to stimulate rational prescribing and secure additional funding through taxation, health insurance or health levy to provide such medicines and services.
Source: Journal of Pharmaceutical Health Services Research - Category: Drugs & Pharmacology Authors: Saval Khanal,
Lennert Veerman,
Lisa Nissen,
Samantha Hollingworth Tags: Research Paper Source Type: research
More News: Australia Health | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Health Insurance | Insurance | Nepal Health | Tax